Moloney Securities Asset Management LLC Has $1.14 Million Position in The Clorox Company $CLX

Moloney Securities Asset Management LLC grew its stake in The Clorox Company (NYSE:CLX) by 3.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,460 shares of the company’s stock after purchasing an additional 302 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Clorox were worth $1,136,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Hsbc Holdings PLC lifted its position in Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock worth $159,699,000 after acquiring an additional 589,544 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its stake in shares of Clorox by 101.8% during the second quarter. Robeco Institutional Asset Management B.V. now owns 1,083,723 shares of the company’s stock worth $130,123,000 after purchasing an additional 546,761 shares during the period. KBC Group NV lifted its holdings in Clorox by 688.7% during the 1st quarter. KBC Group NV now owns 587,679 shares of the company’s stock worth $86,535,000 after purchasing an additional 513,171 shares during the last quarter. AQR Capital Management LLC boosted its stake in Clorox by 412.1% in the 1st quarter. AQR Capital Management LLC now owns 598,758 shares of the company’s stock valued at $88,167,000 after purchasing an additional 481,846 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in Clorox by 147.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock worth $104,107,000 after buying an additional 421,453 shares during the period. Institutional investors own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research report on Tuesday, October 14th. BNP Paribas Exane decreased their target price on shares of Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a research report on Friday, October 17th. Wells Fargo & Company dropped their price target on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Finally, UBS Group dropped their price objective on Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and an average price target of $130.20.

Insider Buying and Selling at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.63% of the stock is currently owned by corporate insiders.

Clorox Trading Down 0.3%

Shares of CLX stock opened at $116.02 on Friday. The Clorox Company has a fifty-two week low of $115.83 and a fifty-two week high of $171.37. The stock’s fifty day moving average price is $121.18 and its two-hundred day moving average price is $127.01. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market cap of $14.13 billion, a PE ratio of 17.79, a P/E/G ratio of 0.96 and a beta of 0.52.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date is Wednesday, October 22nd. Clorox’s payout ratio is 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.